AstraZeneca PLC

AZN.ST·Stockholm·Healthcare
Compare
1,666.00+30.50 (+1.86%)today
At close: Oct 20, 5:29 PM CEST · May be delayed up to 15 min · SEK

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,635.50
Open1,642.50
Day range1,638.001,669.50
52-week range1,467.001,925.50
Off day high−0.21%
Off 52-week high−13.48%
Volume470.43K
Avg. volume (3M)589.77K
Market cap2.58T
EPS (TTM)62.65
Forward P/E—
P/E ratio (TTM)26.59
Dividend yield1.85% (30.24)
Beta (5Y)0.21
Shares outstanding1.55B
Short interest—
Earnings dateOct 30, 2026
Analyst target2,013.09
Profit margin17.02%

Against its peers

Compare in full ›
AZN.ST 4503.T MRK LLY PFE NVS
Market cap 2.58T 4.45T 365.88B 1.14T 171.62B 292.03B
P/E (TTM) 26.6 12.2 117.7 43.1 39.6 23.2
Forward P/E — 32.7 16.0 27.2 10.4 15.7
Price/book 51.4 2.3 8.7 33.8 2.0 7.0
Dividend yield 1.85% 3.29% 2.29% 0.54% 5.71% 3.09%
1-year change +3.94% +50.09% +69.27% +58.00% +21.80% +16.90%
Today +1.86% +1.85% +3.25% +3.49% +2.28% +2.29%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Latest news

All AZN.ST news ›
BusinessLine·Negative

AstraZeneca partners with Oracle for AI-driven clinical trials

AstraZeneca and Oracle launch AI-powered real-world data trials in Abu Dhabi, accelerating recruitment and safety monitoring across multiple diseases AstraZeneca partners with Oracle for AI-driven clinical trials AstraZeneca and Oracle…

ComputerWeekly.com·Positive

AstraZeneca works with Oracle to speed up drug trials

AstraZeneca is working with Oracle to investigate the use of artificial intelligence (AI) and real-world data to help identify eligible patients for clinical trials. The two companies also plan to accelerate evidence generation, and bring…

From articles in the 4Search news index.

In the news

279mentions in 30 days
267with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.